Mortality rate and acute kidney injury prevalence reduction in COVID-19 critical patients treated with hemoperfusion

Introduction: Coronavirus disease 2019 (COVID‑19) induces organic damage mainly through the patient’s immune overreaction. Hemoperfusion (HPF) can remove infl ammatory cytokines and can reduce the negative effects of cytokine storm in COVID‑19. We compared the mortality rate, infl ammatory response,...

Full description

Autores:

Barriga-Moreno, Adriana P.
Lozano Sánchez, Marcela
Barón-Álvarez, Rafael A.
Córdoba, Juan P.
Aroca-Martinez, Gustavo
Dianda, Daniela
González-Torres, Henry Joseth
Musso, Carlos

Tipo de recurso:

Fecha de publicación:

2024

Institución:

Universidad Simón Bolívar

Repositorio:

Repositorio Digital USB

Idioma:

eng

OAI Identifier:

oai:bonga.unisimon.edu.co:20.500.12442/15895

Acceso en línea:

https://hdl.handle.net/20.500.12442/15895
https://pubmed.ncbi.nlm.nih.gov/38645920/

Palabra clave:

Acute kidney injury
COVID‑19
Hemoperfusion

Rights

openAccess

License

Attribution-NonCommercial-NoDerivs 3.0 United States